Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Stem Cells and Development|January 26, 2006
Defined conditions for development of functional hepatic cells from human embryonic stem cellsRobert E Schwartz, Jonathan L Linehan, Matthew S Painschab, et al.
Stem Cell Reports|February 15, 2015
Use of RUNX2 expression to identify osteogenic progenitor cells derived from human embryonic stem cellsLi Zou, Fahad K Kidwai, Ross A Kopher, et al.
Molecular Cancer Therapeutics|August 25, 2011
Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancerNate N Waldron, Dan S Kaufman, Seunguk Oh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2015
Silent IL2RG Gene Editing in Human Pluripotent Stem CellsLi B Li, Chao Ma, Geneve Awong, et al.
Blood|April 15, 2009
Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activityPetter S Woll, Bartosz Grzywacz, Xinghui Tian, et al.
Cytotherapy|September 1, 2022
Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor-natural killer cellsMark Gurney, Eimear O'Reilly, Sarah Corcoran, et al.
Blood|November 10, 2005
Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipientsA Daisy Narayan, Jessica L Chase, Rachel L Lewis, et al.
Experimental Hematology|January 14, 2010
Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell functionKatherine L Hill, Petra Obrtlikova, Diego F Alvarez, et al.
Cytotherapy|September 3, 2013
Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft modelMelissa A Geller, David A Knorr, David A Hermanson, et al.
Journal of Virology|October 22, 2010
Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanismsZhenya Ni, David A Knorr, Christine L Clouser, et al.
Pageof 12